Literature DB >> 7523312

Collagens, integrins and the mesenchymal drift in glioblastomas: a comparison of biopsy specimens, spheroid and early monolayer cultures.

W Paulus1, C Huettner, J C Tonn.   

Abstract

To analyze the process of mesenchymal differentiation in vitro, we examined 5 human glioblastomas as biopsy specimens, monolayer cultures and 3-dimensional fragment spheroid cultures for the immunohistochemical expression of extracellular matrix (ECM) components (collagen types I, III-VI, laminin) and integrin receptors (beta 1, beta 2, beta 3 and beta 4 chains). mRNA for type-I and type-IV collagen alpha I chains was quantified using reverse transcription-polymerase chain reaction. In situ, glioma cells expressed beta 1, the common beta chain of most integrin ECM receptors, while ECM components were restricted to vascular elements. Early monolayer cultures showed a marked increase in ECM components (interstitial collagens more than basement membrane components), and coexpression of ECM components and glial fibrillary acidic protein (GFAP) by most cells. beta 2 and beta 3 integrins were upregulated in the primary cultures. In the fifth passages, GFAP-positive cells were decreased and collagen-expressing cells increased. The spheroids exhibited preserved GFAP staining, neoexpression of beta 4 integrin in some tumors, and variable ECM expression by glioma cells which was lower than that in monolayer cultures. ECM deposition usually commenced in central spheroid areas where the Ki-67 proliferation index was low. We conclude that different culture systems are characterized by distinct expression patterns for ECM components and receptors, and that mesenchymal features in cultured gliomas arise due to transdifferentiation of glioma cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523312     DOI: 10.1002/ijc.2910580616

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions.

Authors:  H Bouterfa; A R Darlapp; E Klein; T Pietsch; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  Long-term exposure to irinotecan reduces cell migration in glioma cells.

Authors:  A B Al-Ghafari; W Punjaruk; L C D Storer; D J Carrier; D Hussein; B Coyle; I D Kerr
Journal:  J Neurooncol       Date:  2016-01-30       Impact factor: 4.130

3.  Glioma expansion in collagen I matrices: analyzing collagen concentration-dependent growth and motility patterns.

Authors:  L J Kaufman; C P Brangwynne; K E Kasza; E Filippidi; V D Gordon; T S Deisboeck; D A Weitz
Journal:  Biophys J       Date:  2005-04-22       Impact factor: 4.033

4.  Adaptation of an automated selective dissociation procedure to two novel spheroid types.

Authors:  L A Kunz-Schughart; J P Freyer
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-02       Impact factor: 2.416

5.  Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.

Authors:  Basavaraj Vastrad; Chanabasayya Vastrad; Ashok Godavarthi; Raghu Chandrashekar
Journal:  Med Oncol       Date:  2017-09-26       Impact factor: 3.064

Review 6.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

7.  Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.

Authors:  Petr Busek; Eva Balaziova; Ivana Matrasova; Marek Hilser; Robert Tomas; Martin Syrucek; Zuzana Zemanova; Evzen Krepela; Jaromir Belacek; Aleksi Sedo
Journal:  Tumour Biol       Date:  2016-08-04

Review 8.  Models for assessment of angiogenesis in gliomas.

Authors:  R H Goldbrunner; S Wagner; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 9.  Interactions of glioma cells and extracellular matrix.

Authors:  W Paulus; J C Tonn
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma.

Authors:  Sonja Mertsch; Leon J Schurgers; Kathrin Weber; Werner Paulus; Volker Senner
Journal:  BMC Cancer       Date:  2009-08-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.